These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8364287

  • 1. Use of theophylline to control hematocrit in respiratory polycythemia.
    Souweine B, Serre AF, Fialip J, Jimenez C, Philippe P.
    Ann Pharmacother; 1993; 27(7-8):978. PubMed ID: 8364287
    [No Abstract] [Full Text] [Related]

  • 2. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.
    Oren R, Beeri M, Hubert A, Kramer MR, Matzner Y.
    Arch Intern Med; 1997 Jul 14; 157(13):1474-8. PubMed ID: 9224226
    [Abstract] [Full Text] [Related]

  • 3. Polycythemia in chronic obstructive pulmonary disease. A study of serum and urine erythropoietin and medullary erythroid progenitors.
    Guidet B, Offenstadt G, Boffa G, Najman A, Baillou C, Hatzfeld C, Amstutz P.
    Chest; 1987 Nov 14; 92(5):867-70. PubMed ID: 3665602
    [Abstract] [Full Text] [Related]

  • 4. High haematocrit in haemodialysis patients can be controlled by theophylline administration.
    Vereerstraeten A, Gastaldello K, Gervy C, Vanherweghem JL, Tielemans C.
    Nephrol Dial Transplant; 1994 Nov 14; 9(2):189-91. PubMed ID: 8190338
    [Abstract] [Full Text] [Related]

  • 5. Theophylline modulates erythrocytosis after renal transplantation.
    Grekas D, Dioudis C, Valkouma D, Papoulidou F, Tourkantonis A.
    Nephron; 1995 Nov 14; 70(1):25-7. PubMed ID: 7617113
    [Abstract] [Full Text] [Related]

  • 6. Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis.
    Vlahakos DV, Marathias KP, Kosmas EN.
    Ann Intern Med; 2001 Mar 06; 134(5):426-7. PubMed ID: 11242510
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of respiratory insufficiency in chronic nonspecific lung diseases].
    Kazanbiev NK.
    Klin Med (Mosk); 1995 Mar 06; 73(4):24-7. PubMed ID: 7474811
    [No Abstract] [Full Text] [Related]

  • 8. Optimal hematocrit and blood viscosity in secondary polycythemia as determined from cerebral blood flow.
    Menon D, York EL, Bornstein RA, Jones RL, Sproule BJ.
    Clin Invest Med; 1981 Mar 06; 4(2):117-21. PubMed ID: 7285399
    [No Abstract] [Full Text] [Related]

  • 9. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease.
    Vlahakos DV, Kosmas EN, Dimopoulou I, Ikonomou E, Jullien G, Vassilakos P, Marathias KP.
    Am J Med; 1999 Feb 06; 106(2):158-64. PubMed ID: 10230744
    [Abstract] [Full Text] [Related]

  • 10. Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia.
    Wedzicha JA, Cotes PM, Empey DW, Newland AC, Royston JP, Tam RC.
    Clin Sci (Lond); 1985 Oct 06; 69(4):413-22. PubMed ID: 4042542
    [Abstract] [Full Text] [Related]

  • 11. [Effects of theophylline on the course of hypercapnic respiratory insufficiency].
    Chiappini F, Bevignani G, Fresu R.
    Clin Ter; 1990 Oct 31; 135(2):121-7. PubMed ID: 2149545
    [Abstract] [Full Text] [Related]

  • 12. [Increase of arterial oxygen pressure in therapy with theophylline in patients with obstructive ventilation disorder and partial respiratory insufficiency].
    Schmidt EW, Ulmer WT.
    Prax Klin Pneumol; 1988 Jul 31; 42(7):600-2. PubMed ID: 3054862
    [No Abstract] [Full Text] [Related]

  • 13. Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment.
    Cazzola M, Guarnone R, Cerani P, Rovati A, Ascari E.
    Blood; 1998 Jan 01; 91(1):360-1. PubMed ID: 9414308
    [No Abstract] [Full Text] [Related]

  • 14. Erythrapheresis compared with placebo apheresis in patients with polycythaemia secondary to hypoxic lung disease.
    Wedzicha JA, Cotter FE, Rudd RM, Apps MC, Newland AC, Empey DW.
    Eur J Respir Dis; 1984 Nov 01; 65(8):579-85. PubMed ID: 6519213
    [Abstract] [Full Text] [Related]

  • 15. [Theophylline therapy in obstructive respiratory diseases. 2. Theophyllin-retard preparations for the long-term treatment of non-smokers with or without cardiac insufficiency (author's transl)].
    Wemhöner S, Oellerich M, Sybrecht G.
    Prax Klin Pneumol; 1981 Jan 01; 35(1):42-6. PubMed ID: 6782562
    [No Abstract] [Full Text] [Related]

  • 16. Effect of hematocrit on the blood viscosity of patients with chronic respiratory failure and secondary polycythemia.
    Clivati A, Marazzini L, Agosti R, Gatto R, Longhini E.
    Respiration; 1980 Jan 01; 40(4):201-7. PubMed ID: 7221192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of secondary polycythaemia in chronic airways obstruction.
    Stradling JR, Lane DJ.
    Thorax; 1981 May 01; 36(5):321-5. PubMed ID: 7031963
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Study of P50 in polycythaemia.
    Verdier F, Neukirch F, Fay M, Timsit G, Legrand M, Drutel P.
    Biomedicine; 1977 Mar 01; 27(2):85-8. PubMed ID: 861357
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.